http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112021025034-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ff8b5e99c6a76b1b2b591716f2952af
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e45d4823ea062307dd43c920c63ffb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0809e384f1b6b45ca2f3e0abe4408a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b1b061638202c907a534f1654670a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15936608e1fff16aa03b9f214dc62265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99ea3c54e7e476e89eaa9bed53f2abff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16717b7bb4a37adcf136ad9c3a0e7bcc
publicationDate 2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112021025034-A2
titleOfInvention Immunoconjugate, aminobenzazepine-ligand compound, pharmaceutical composition, methods for treating cancer and for preparing an immunoconjugate and use of an immunoconjugate
abstract immunoconjugate, aminobenzazepine-ligand compound, pharmaceutical composition, methods for treating cancer and for preparing an immunoconjugate and use of an immunoconjugate. the application relates to immunoconjugates of formula (I) comprising an antibody linked by conjugation to one or more aminobenzazepine derivatives. the application also provides intermediate compositions of aminobenzazepine derivatives of formula (ii) comprising a reactive functional group. such intermediate compositions are suitable substrates for forming the immunoconjugates through a linker or binding moiety. the application further provides the above-mentioned immunoconjugates for use in cancer treatment methods.
priorityDate 2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22135215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421003524

Total number of triples: 38.